Showing results (2581-2590 of 3,512) with videos related to
Sort By:
Pageof 352
Eclinicalmedicine|July 19, 2026
The global cancer mental health survey: insights from patient and provider experiences on psychosocial care accessJuan P Borda, Gilla K Shapiro, William E Rosa, et al.Eclinicalmedicine|July 19, 2026
Trends and evolution of metabolic bariatric surgery over a decade: analysis of IFSO global registry reports' data collection, clinical trends, and a FAIR-informed appraisal of report-level transparencyMohamed Hany, Bart Torensma, Mohamed H Zidan, et al.Eclinicalmedicine|July 19, 2026
Efficacy and safety of HRS-7535, an oral small-molecule GLP-1 receptor agonist, in patients with diabetic kidney disease (SOLID-DKD): a randomised, double-blind, placebo-controlled, phase 2 trialRong Lv, Liang Peng, Yimei Xu, et al.Eclinicalmedicine|August 23, 2026
Longitudinal patterns of fentanyl utilisation (medical versus illicit sources) in the United States 2015-2023: a retrospective cohort studySeungyeon Lee, Wenyu Song, David W Bates, et al.Eclinicalmedicine|August 14, 2026
Sustained benefit of compression therapy for preventing recurrent leg cellulitis: extended follow-up of a randomised controlled trialElizabeth Webb, Teresa Neeman, Francis J Bowden, et al.Eclinicalmedicine|July 28, 2026
Compression systems for venous leg ulcers: a network meta-analysis and cost-effectiveness analysisHan Phung, Catherine Arundel, Jo Dumville, et al.Eclinicalmedicine|August 8, 2026
Integrated care programmes for severe mental illnesses and comorbid physical health disorders: the EU-MIND umbrella review to inform future actions in EuropeUlker Isayeva, Esther Touitou-Burckard, Alicja Bukowska, et al.Eclinicalmedicine|August 15, 2026
Mediterranean lifestyle and risk of adverse cardiovascular events, all-cause and cardiovascular mortality among individuals with type 2 diabetesMaría Del Carmen Aznar de la Riera, Jesús Díaz-Gutiérrez, Stefanos N Kales, et al.Eclinicalmedicine|August 16, 2026
[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2-3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trialDiego Ferone, Marianne Pavel, Ken Herrmann, et al.Eclinicalmedicine|September 23, 2026
Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancerLotte M G Hulskotte, G D Marijn Veerman, Daan A C Lanser, et al.Pageof 352